Analyst Reco. Keurig Dr Pepper Inc.

Equities

KDP

US49271V1008

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
33.72 ^USD	-0.35%		+7.05%	+1.20%

06:20pm	Keurig Dr Pepper's Coffee Business Could Accelerate Organic Revenue Growth, UBS Says	MT
05:27pm	JPMorgan Adjusts Keurig Dr Pepper's Price Target to $37 From $34	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

JPMorgan Adjusts Keurig Dr Pepper's Price Target to $37 From $34	11:27am	MT
Jefferies Adjusts Keurig Dr Pepper's Price Target to $39 From $35	11:27am	MT
Wedbush Adjusts Keurig Dr Pepper's Price Target to $37 From $35 After 'Strong' Q1 Beat, Keeps Outperform Rating	11:06am	MT
UBS Adjusts Keurig Dr Pepper Price Target to $39 From $36, Maintains Buy Rating	10:58am	MT
TD Cowen Adjusts Keurig Dr Pepper's Price Target to $35 From $32	10:49am	MT
Bernstein Adjusts Price Target on Keurig Dr Pepper to $39 From $36	10:07am	MT
Morgan Stanley Adjusts Price Target on Keurig Dr Pepper to $36 From $34	08:45am	MT
Wells Fargo Adjusts Price Target on Keurig Dr Pepper to $39 From $37	07:59am	MT
Barclays Raises Keurig Dr Pepper's Price Target to $38 From $36	07:57am	MT
Citigroup Adjusts Price Target on Keurig Dr Pepper to $35 From $33	07:42am	MT
Evercore ISI Adjusts Keurig Dr Pepper Price Target to $36 From $34, Keeps In Line Rating	Apr. 25	MT
Deutsche Bank Adjusts Keurig Dr Pepper Price Target to $34 From $33, Maintains Hold Rating	Apr. 15	MT
Consumer Edge Adjusts Keurig Dr Pepper's Price Target to $41 From $40	Apr. 15	MT
Barclays Adjusts Price Target on Keurig Dr Pepper to $36 From $32, Maintains Overweight Rating	Apr. 12	MT
Jefferies Cuts Keurig Dr Pepper's Price Target to $35 From $37, Keeps Buy Rating	Mar. 27	MT
Barclays Cuts Price Target on Keurig Dr Pepper to $32 From $34, Keeps Overweight Rating	Mar. 12	MT
ANALYST RECOMMENDATIONS : Block, Estee Lauder, Dell, Netflix, Nvidia...	Mar. 01
Morgan Stanley Cuts Price Target on Keurig Dr Pepper to $34 From $37, Keeps Equalweight Rating	Feb. 26	MT
Wedbush Lowers Keurig Dr Pepper's PT to $35 From $37 After Mixed Q4 2023 Results, Maintains Outperform Rating	Feb. 26	MT
Barclays Cuts Price Target on Keurig Dr Pepper to $34 From $37, Maintains Overweight Rating	Feb. 23	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Keurig Dr Pepper Inc.

Equities

KDP

US49271V1008

Analyst Reco.

Filters